Profile of antibodies against Epstein-Barr virus in patients with blood disorders

• Autorzy: Zuk-Wasek A. , Litwinska B. , Traczyk Z.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to investigate the profile of Epstein-Barr virus (EBV) antibodies and to compare this profile with the detectability of EBV DNA and compare this profile in healthy people with the profile in patients with blood disorders. The profile of antibodies was examined in serum from the following groups: 40 patients with blood disorders, but without EBV DNA in their lymphocytes, 44 patients with blood disorders and EBV DNA in lymphocytes, and 46 healthy people. EBV antibodies were detected by using ELISA commercial kits. The obtained results were analysed by Fisher's exact test. No significant differences in antibody profiles were found between EBV DNA-positive and EBV DNA-negative sera. Between patients and the control group, considerable differences were observed in reactivation and in past infection, and a significant difference was observed in chronic infection. These analyses suggest that EBV reactivation or chronic infection can be related with blood disorders and have an influence on the course of blood disorders.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 4
• Opis fizyczny: p.507-510,fig.,ref.

Twórcy

autor

Zuk-Wasek A.

• Department of Virology, National Institute of Public Health - National Institute of Hygiene, 00-791 Warsaw, Poland

autor

Litwinska B.

• Department of Virology, National Institute of Public Health - National Institute of Hygiene, 00-791 Warsaw, Poland

autor

Traczyk Z.

• Department of Internal Diseases, Institute of Haematology and Transfusiology, 02-776 Warsaw, Poland

Bibliografia

• 1. Akiba S., Koriyama C., Herrera-Goepfert R., Eizuru Y.: Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci 2008, 99, 195-201.
• 2. Bauer G.: The rational basis of efficient Epstein-Barr virus (EBV) serology. Clin Lab 1995, 41, 623-634.
• 3. Buisson M., Fleurent B., Mak M., Morand P., Chan L., Ng A., Guan M., Chin D., Seigneurin J.M.: Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J Clin Microbiol 1999, 37, 2709-2714.
• 4. Flisher G.R.: Epstein-Barr virus In: Textbook of Human Virology. Edited by Belshe R.B., PSG Publishing Company, Littleton, 1984, pp. 853-886.
• 5. Grazi G., Balisteri M., Schito G.C.: Recombinant antigens in the serodiagnosis of EBV-infections. Biotest Bull 1993, 5, 47-50.
• 6. Hinderer W., Nebel-Schickel H., Horn J., Vornhagen R., Wenger-Suss R., Sonneborn H.-H.: The biotest anti- EBV recombinant ELISA system: recent studies, progress in interpretation, and future trends. Biotest Bull 1993, 5, 33- 46.
• 7. Lennette E. T.: Epstein-Barr Virus In: Laboratory diagnosis of viral infections. Edited by Lenntet E.H., Dekker M., New York, Basel, Hong Kong, 1992, pp. 365- 380.
• 8. Litwińska B., Trzcińska A.: Diagnosis of EBV infection - methods, problems and interpretation of results. Bull Vet Inst Pulawy 2002, Suppl., 57-63.
• 9. Lopes V., Lawrence S.Y., Murray P.G.: Epstein-Barr virus - associated cancers: aetiology and treatment. Herpes 2003, 10, 78-82.
• 10. Matter L., Gorgievski M., Montandon A., Germann D., Telenti A.: Epstein-Barr virus (EBV) antibody patterns and circulating EBV in immunocompromised hosts. Biotest Bull 1993, 5, 27-31.
• 11. Parammita D.K., Fachiron J., Haryana S.M., Middeldorp J.M.: Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma. J Clin Virol 2008, 42, 343-352.
• 12. Rickinson A.B., Kieff E.: Epstein-Barr virus. In: Field's Virology. Edited by Lippincott-Wiliams&Wilkins Philaddelphia, 2001, Chapter 74, pp. 2397-2446.
• 13. Schetter A.J., You W.C., Lennette E.T., Gail M.T., Rabkin C.S.: Association of Epstein-Barr virus antibody levels with precancerous gastric lesions in a high-risk cohort. Cancer Sci 2008, 99, 350-354.
• 14. Wutzler P.: Diagnosis of Epsteinn-Barr virus infections. Biotest Bull 1993, 5, 21-26.
• 15. Żuk-Wasek A., Litwińska B., Traczyk Z.: Presence of herpesviruses DNA in lymphocytes isolated from patients with blood disorders. Bull Vet Inst Pulawy 2008, 52, 511-515.